Patricia Konstantaros
Family · Cedar Grove, NJNPI 1114397072
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,089 and has fallen 88.5% since, to $125 in 2025.
Across 67 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$286
- Boehringer Ingelheim$184
- GSK$141
- Lilly USA, LLC$105
- Merck$78
- Amarin Pharma, Inc.$59
- plus $378 from 15 others
What the payments were for
- Food & beverage$1,231100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $286 |
| Boehringer Ingelheim | 6 | $184 |
| GSK | 10 | $141 |
| Lilly USA, LLC | 8 | $105 |
| Merck | 6 | $78 |
| Amarin Pharma, Inc. | 4 | $59 |
| AstraZeneca | 4 | $57 |
| Jazz Pharmaceuticals Inc. | 4 | $56 |
| Amgen | 4 | $54 |
| Nestle Healthcare Nutrition Inc. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 2 | $28 |
| AbbVie | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,231 in reported general payments places this provider in the 80th percentile of 2,692 family providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $4,387 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $938 |
| Cyclobenzaprine Hcl | 23 | $207 |
Paid to pharmacies, not to this prescriber.
Other family in Cedar Grove
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.